West Pharmaceutical Services, Inc. (WST)
Company Info
US9553061055
955306105
Jan 13, 1978
Highlights
$14.85B
$6.37
32.45
3.63
$2.90B
$1.00B
$729.50M
$187.25 - $355.10
$281.92
4.61%
2.28
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
West Pharmaceutical Services, Inc. (WST) returned -35.58% year-to-date (YTD) and -39.89% over the past 12 months. Over the past 10 years, WST delivered an annualized return of 14.91%, outperforming the S&P 500 benchmark at 10.79%.
WST
-35.58%
-0.76%
-37.59%
-39.89%
-0.09%
14.91%
^GSPC (Benchmark)
0.60%
9.64%
-0.54%
11.47%
15.67%
10.79%
Monthly Returns
The table below presents the monthly returns of WST, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 4.27% | -31.93% | -3.64% | -5.53% | -0.29% | -35.58% | |||||||
| 2024 | 6.00% | -3.93% | 10.42% | -9.61% | -7.29% | -0.61% | -6.99% | 2.44% | -4.29% | 2.59% | 5.83% | 0.58% | -6.75% |
| 2023 | 12.93% | 19.36% | 9.29% | 4.32% | -7.37% | 14.30% | -3.72% | 10.56% | -7.79% | -15.17% | 10.27% | 0.39% | 49.97% |
| 2022 | -16.12% | -1.56% | 6.10% | -23.25% | -1.49% | -2.58% | 13.69% | -13.64% | -17.06% | -6.49% | 2.07% | 0.29% | -49.70% |
| 2021 | 5.77% | -6.29% | 0.40% | 16.65% | 5.78% | 3.34% | 14.71% | 9.69% | -6.00% | 1.26% | 3.02% | 5.95% | 65.88% |
| 2020 | 3.84% | -3.46% | 1.12% | 24.43% | 14.15% | 5.15% | 18.43% | 5.61% | -3.19% | -1.03% | 1.19% | 2.96% | 89.05% |
| 2019 | 10.60% | -3.25% | 5.20% | 12.48% | -7.42% | 9.21% | 9.82% | 5.97% | -2.50% | 1.54% | 2.22% | 2.24% | 54.13% |
| 2018 | 1.70% | -12.95% | 1.23% | 0.07% | 5.43% | 6.76% | 10.59% | 6.75% | 5.48% | -14.10% | 3.44% | -10.52% | -0.08% |
| 2017 | -0.08% | -2.55% | -1.04% | 12.95% | 5.42% | -2.58% | -6.03% | -1.87% | 10.59% | 5.49% | -1.45% | -1.26% | 17.02% |
| 2016 | -4.78% | 8.39% | 11.77% | 2.89% | 5.45% | 1.07% | 5.96% | 1.93% | -8.96% | 2.24% | 6.73% | 4.53% | 41.87% |
| 2015 | -7.18% | 10.97% | 10.03% | -11.33% | 1.61% | 7.28% | 3.27% | -6.71% | -3.10% | 11.12% | 5.07% | -4.49% | 14.03% |
| 2014 | -3.09% | -3.94% | -3.36% | -1.29% | -2.97% | 0.21% | -3.15% | 6.58% | 3.06% | 14.78% | 1.48% | 2.36% | 9.53% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of WST is 10, meaning it’s performing worse than 90% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
West Pharmaceutical Services, Inc. provided a 0.39% dividend yield over the last twelve months, with an annual payout of $0.83 per share. The company has been increasing its dividends for 28 consecutive years, earning it the status of a dividend aristocrat.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.83 | $0.81 | $0.77 | $0.73 | $0.69 | $0.65 | $0.61 | $0.57 | $0.53 | $0.49 | $0.45 | $0.41 |
Dividend yield | 0.39% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Monthly Dividends
The table displays the monthly dividend distributions for West Pharmaceutical Services, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.21 | $0.00 | $0.21 | $0.00 | $0.42 | |||||||
| 2024 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.00 | $0.21 | $0.00 | $0.81 |
| 2023 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.00 | $0.20 | $0.00 | $0.77 |
| 2022 | $0.18 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.00 | $0.19 | $0.00 | $0.73 |
| 2021 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.00 | $0.18 | $0.00 | $0.69 |
| 2020 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.00 | $0.17 | $0.00 | $0.65 |
| 2019 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.61 |
| 2018 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.57 |
| 2017 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.53 |
| 2016 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.49 |
| 2015 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.45 |
| 2014 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.41 |
Dividend Yield & Payout
Dividend Yield
West Pharmaceutical Services, Inc. has a dividend yield of 0.39%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
West Pharmaceutical Services, Inc. has a payout ratio of 12.50%, which is below the market average. This means West Pharmaceutical Services, Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the West Pharmaceutical Services, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the West Pharmaceutical Services, Inc. was 59.29%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current West Pharmaceutical Services, Inc. drawdown is 54.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -59.29% | Dec 31, 2021 | 820 | Apr 8, 2025 | — | — | — |
| -54.76% | Jul 23, 1999 | 816 | Oct 22, 2002 | 288 | Dec 12, 2003 | 1104 |
| -50.52% | Oct 5, 1989 | 285 | Nov 21, 1990 | 371 | May 18, 1992 | 656 |
| -45.12% | Sep 22, 2008 | 116 | Mar 9, 2009 | 824 | Jun 13, 2012 | 940 |
| -43.08% | Jun 8, 1987 | 238 | May 13, 1988 | 309 | Aug 3, 1989 | 547 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of West Pharmaceutical Services, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of West Pharmaceutical Services, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 15.3% positive surprise.
Valuation
The Valuation section provides an overview of how West Pharmaceutical Services, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for WST, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, WST has a P/E ratio of 32.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for WST compared to other companies in the Medical Instruments & Supplies industry. WST currently has a PEG ratio of 3.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for WST relative to other companies in the Medical Instruments & Supplies industry. Currently, WST has a P/S ratio of 5.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for WST in comparison with other companies in the Medical Instruments & Supplies industry. Currently, WST has a P/B value of 5.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |